XML 50 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock Award Plans (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Compensation Cost Breakdown in Statement of Earnings

The Company has share-based compensation plans which are described below. The compensation cost that has been charged against earnings for the Company’s stock award plans and the income tax benefit recognized in the statement of earnings for stock awards were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Compensation cost

 

$

15,549

 

 

$

14,941

 

 

$

13,865

 

Income tax benefit

 

$

3,716

 

 

$

3,616

 

 

$

3,533

 

Stock Option Valuation Assumptions

The key input variables used in valuing the stock options granted in 2023 were as follows:

 

 

 

Year Ended December 31,

 

 

 

2023

 

Dividend yield

 

None

 

Average risk-free interest rate

 

 

3.7

%

Stock price volatility

 

 

35

%

Estimated option term

 

7 years

 

Employee Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Option Activity

The following is a summary of the stock option activity under the employee plan described above:

 

 

 

Outstanding
Non-Qualified or
Nonincentive
Stock Option
Awards

 

 

Weighted
Average
Exercise
Price

 

Outstanding at December 31, 2023

 

 

255,245

 

 

$

74.00

 

Exercised

 

 

(124,397

)

 

$

74.35

 

Expired

 

 

 

 

$

 

Outstanding at December 31, 2024

 

 

130,848

 

 

$

73.66

 

Outstanding and Exercisable Stock Options

The following table summarizes information about the Company’s outstanding and exercisable stock options under the employee plan at December 31, 2024:

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of Exercise
Prices

 

Number
Outstanding

 

 

Weighted
Average
Remaining
Contractual
Life in
Years

 

 

Weighted
Average
Exercise
Price

 

 

Aggregated
Intrinsic
Value
(in thousands)

 

 

Number
Exercisable

 

 

Weighted
Average
Exercise
Price

 

 

Aggregated
Intrinsic
Value
(in thousands)

 

$73.29

 

 

70,038

 

 

 

1.1

 

 

$

73.29

 

 

 

 

 

 

70,038

 

 

$

73.29

 

 

 

 

$73.93

 

 

54,879

 

 

 

0.5

 

 

$

73.93

 

 

 

 

 

 

54,879

 

 

$

73.93

 

 

 

 

$75.50

 

 

5,931

 

 

 

 

 

$

75.50

 

 

 

 

 

 

5,931

 

 

$

75.50

 

 

 

 

$73.29 – $75.50

 

 

130,848

 

 

 

1.6

 

 

$

73.66

 

 

$

4,206

 

 

 

130,848

 

 

$

73.66

 

 

$

4,206

 

RSU Activity

The following is a summary of RSU activity under the employee plan described above:

 

 

 

Unvested RSUs

 

 

Weighted
Average Grant
Date Fair Value
Per Unit

 

Nonvested balance at December 31, 2023

 

 

554,604

 

 

$

64.61

 

Granted

 

 

167,290

 

 

$

84.12

 

Vested

 

 

(192,585

)

 

$

63.06

 

Forfeited

 

 

(13,930

)

 

$

68.08

 

Nonvested balance at December 31, 2024

 

 

515,379

 

 

$

71.43

 

Director Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock Option Activity

The following is a summary of the stock option activity under the director plan described above:

 

 

 

Outstanding
Non-Qualified or
Nonincentive
Stock Option
Awards

 

 

Weighted
Average
Exercise
Price

 

Outstanding at December 31, 2023

 

 

30,345

 

 

$

90.57

 

Exercised

 

 

(21,865

)

 

$

94.80

 

Expired

 

 

 

 

$

 

Outstanding at December 31, 2024

 

 

8,480

 

 

$

79.67

 

Outstanding and Exercisable Stock Options

The following table summarizes information about the Company’s outstanding and exercisable stock options under the director plan at December 31, 2024:

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of Exercise
Prices

 

Number
Outstanding

 

 

Weighted
Average
Remaining
Contractual
Life in
Years

 

 

Weighted
Average
Exercise
Price

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

 

Number
Exercisable

 

 

Weighted
Average
Exercise
Price

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

$70.65

 

 

3,188

 

 

 

0.9

 

 

$

70.65

 

 

 

 

 

 

3,188

 

 

$

70.65

 

 

 

 

$84.90

 

 

2,652

 

 

 

1.4

 

 

$

84.90

 

 

 

 

 

 

2,652

 

 

$

84.90

 

 

 

 

$85.30

 

 

2,640

 

 

 

1.0

 

 

$

85.30

 

 

 

 

 

 

2,640

 

 

$

85.30

 

 

 

 

$70.65 – $85.30

 

 

8,480

 

 

 

3.3

 

 

$

79.67

 

 

$

222

 

 

 

8,480

 

 

$

79.67

 

 

$

222

 

Restricted Stock Award Activity

The following is a summary of the restricted stock award activity under the director plan described above:

 

 

 

Unvested
Restricted
Stock Award
Shares

 

 

Weighted
Average
Grant Date
Fair Value
Per Share

 

Nonvested balance at December 31, 2023

 

 

620

 

 

$

72.65

 

Granted

 

 

14,624

 

 

$

109.99

 

Vested

 

 

(15,244

)

 

$

108.47

 

Nonvested balance at December 31, 2024

 

 

 

 

$